QUI Yao-ling,CAO Hui,GAO Xuri,KASS Jorden,LI Wei,PENG Xiaowen,SUH Byung-chul,OR Yat Sun
申请号：
IL27294120
公开号：
IL272941D0
申请日:
2020.02.27
申请国别(地区):
IL
年份:
2020
代理人:
摘要：
which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
